文献速递临床微生物分子诊断

观点交锋:艰难梭菌感染检测的最优策略是什么?

Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?
PubMed 文献 · J Clin Microbiol · 2017-01-11

本文以问答形式呈现艰难梭菌感染(CDI)实验室诊断的观点交锋。Fang主张仅用核酸扩增试验(NAAT),Polage与Wilcox则讨论毒素检测在诊断中的价值。背景是NAAT已成为美国CDI诊断主流方法,但文献提示其缺乏临床特异性可能高估CDI发生率,且医院CDI率被公开报告并影响安全评级与按价值购买。

要点

  • NAAT已成为美国CDI诊断的主要方法,但可能缺乏临床特异性。
  • 毒素检测在CDI诊断中的价值是本次观点交锋的另一核心议题。
  • 医院CDI率被公开报告,可能影响安全评级与按价值购买。

核心结论

  • NAAT仅用策略与包含毒素检测的策略在CDI诊断中的最优性存在观点交锋。

研究设计与样本

  • 采用常见问题问答形式的观点交锋,由Fang陈述NAAT仅用策略的价值,Polage与Wilcox讨论毒素检测的影响。

主要发现

  • NAAT已在美国市场广泛可及并成为CDI诊断 predominant 方法。
  • 有文献提示NAAT缺乏临床特异性,可能高估CDI发生率。
  • 医院CDI率被公开报告,成为影响医院安全评级与按价值购买的重要指标,可能涉及数百万美元报销风险。

临床怎么用

  • 检验科在选择CDI诊断策略时需权衡NAAT的高灵敏度与毒素检测的临床特异性。
  • 应关注医院CDI率公开报告对机构安全评级和报销的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTIONIn 2010, we published an initial Point-Counterpoint on the laboratory diagnosis of Clostridium difficile infection (CDI). At that time, nucleic acid amplification tests (NAATs) were just becoming commercially available, and the idea of algorithmic approaches to CDI was being explored. Now, there are numerous NAATs in the marketplace, and based on recent proficiency test surveys, they have become the predominant method used for CDI diagnosis in the United States. At the same time, there is a body of literature that suggests that NAATs lack clinical specificity and thus inflate CDI rates. Hospital administrators are taking note of institutional CDI rates because they are publicly reported. They have become an important metric impacting hospital safety ratings and value-based purchasing; hospitals may have millions of dollars of reimbursement at risk. In this Point-Counterpoint using a frequently asked question approach, Ferric Fang of the University of Washington, who has been a consistent advocate for a NAAT-only approach for CDI diagnosis, will discuss the value of a NAAT-only approach, while Christopher Polage of the University of California Davis and Mark Wilcox of Leeds University, Leeds, United Kingdom, each of whom has recently written important articles on the value of toxin detection in the diagnosis, will discuss the impact of toxin detection in CDI diagnosis.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Fang FC, Polage CR, Wilcox MH, et al. Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection? J Clin Microbiol. 2017. PMID: 28077697. doi:10.1128/JCM.02463-16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。